Alyeska Investment Group, L.P. Bio Techne Corp Transaction History

Alyeska Investment Group, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $442,329 - $516,811	6,704 Added 0.74%	911,526 $64.2 Million
Q4 2023 Feb 14, 2024	SELL	$52.83 - $78.22 $9.77 Million - $14.5 Million	-184,965 Reduced 16.97%	904,822 $69.8 Million
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $80.4 Million - $93.7 Million	1,089,787 New	1,089,787 $89 Million
Q3 2020 Nov 16, 2020	BUY	$232.22 - $282.96 $1.68 Million - $2.05 Million	7,255 Added 8.74%	90,303 $22.4 Million
Q2 2020 Aug 14, 2020	BUY	$185.43 - $279.56 $3.57 Million - $5.38 Million	19,248 Added 30.17%	83,048 $21.9 Million
Q1 2020 May 15, 2020	BUY	$161.17 - $221.51 $9.82 Million - $13.5 Million	60,920 Added 2115.28%	63,800 $12.1 Million
Q4 2019 Feb 14, 2020	SELL	$189.68 - $222.09 $612,476 - $717,128	-3,229 Reduced 52.86%	2,880 $632,000
Q1 2019 May 15, 2019	BUY	$136.09 - $200.44 $831,373 - $1.22 Million	6,109 New	6,109 $0

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.79B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.